Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
CHR-5154
print preview
bookmark
share with colleague
General Information
Company
Chroma Therapeutics Ltd.
Description
Macrophage-targeted histone deacetylase (HDAC) inhibitor
Molecular Target
Histone deacetylase (HDAC)
Mechanism of Action
Histone deacetylase (HDAC) inhibitor
Latest Stage of Development
Preclinical
Indication
Inflammation
Partner
GlaxoSmithKline plc
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy